4.7 Article

Paper-based ELISA for fast CA 15-3 detection in point-of-care

期刊

MICROCHEMICAL JOURNAL
卷 181, 期 -, 页码 -

出版社

ELSEVIER
DOI: 10.1016/j.microc.2022.107756

关键词

paper-based ELISA; CA15-3; Colorimetric detection; Cancer detection; Breast cancer

资金

  1. project TecniCOV [POCI-01-02B7-FEDER-069745]
  2. Fundaao para a Ciencia e Tecnologia, I.P. [SFRH/BD/131959/2017, UIDB/04469/2020 unit]

向作者/读者索取更多资源

A paper-based colorimetric assay was developed for the detection of cancer biomarker CA 15-3. The assay is rapid, simple, and relatively inexpensive, making it suitable for analysis of serum samples.
The paper-based Enzyme-Linked Immunosorbent Assay (P-ELISA) is a promising tool for diagnostic applications because the paper matrix is characterised by low cost, short analysis time, portability, and a high surface-to-volume ratio that allows the use of a small sample and reagent volume of a few microliters. In addition, colorimetric assays are suitable for low-resource areas due to their simplicity and naked-eye detectability. Although several works have been reported using paper-based colorimetric sensors for cancer biomarkers, P-ELISA for cancer antigen 15-3 (CA 15-3) has never been reported. Thus, this work reports the development of a rapid, simple and relatively inexpensive paper-based colorimetric assay for the detection of CA 15-3 as cancer biomarker. The assay was developed on a filter paper that was previously washed and chemically oxidized with periodate to generate aldehyde functional groups on the cellulose surface. After covalent binding of the first antibody, detection was performed by a colorimetric reaction based on the oxidation of the substrate 3,3',5,5' -tetramethylbenzidine (TMB) by a peroxidase enzyme in the presence of H2O2. The colorimetric measurement was based on digital image acquisition analysed using ImageJ software. The linear range of the assay in buffer ranged 2 to 1100 U/mL. The performance of the assay was also successfully tested in human serum from Cormay (R), offering a linear range from 2 to 200 U/mL. Thus, this P-ELISA sensor is suitable for the analysis of serum samples, since the physiological value in cancer patients is 30 U/mL. We believe that this proof-of-concept has the potential to be extended to be applied to other protein biomarkers and to be a suitable tool for cancer screening in developing countries.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据